- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/46 - Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Patent holdings for IPC class C07D 277/46
Total number of patents in this class: 382
10-year publication summary
23
|
24
|
25
|
21
|
17
|
23
|
28
|
15
|
13
|
17
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
City of Hope | 989 |
9 |
Romark Laboratories L.C. | 52 |
9 |
The Regents of the University of California | 19918 |
8 |
Boehringer Ingelheim International GmbH | 4650 |
7 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
7 |
Bristol-myers Squibb Company | 4898 |
6 |
The Board of Trustees of the Leland Stanford Junior University | 6408 |
6 |
Theravance Biopharma R&D IP, LLC | 458 |
6 |
Abbott Laboratories | 2399 |
5 |
Centre National de La Recherche Scientifique | 10418 |
5 |
Northwestern University | 3389 |
5 |
Foghorn Therapeutics Inc. | 125 |
5 |
The Scripps Research Institute | 1346 |
5 |
Sanofi | 4055 |
5 |
Novartis AG | 10849 |
4 |
Annji Pharmaceutical Co., Ltd. | 15 |
4 |
Beiersdorf AG | 3014 |
4 |
Dana-Farber Cancer Institute, Inc. | 2571 |
4 |
Masarykova Univerzita | 70 |
4 |
Shionogi & Co., Ltd. | 854 |
4 |
Other owners | 270 |